01.12.2015 | Research article | Ausgabe 1/2015 Open Access

Comparison of the quadriceps-sparing and subvastus approaches versus the standard parapatellar approach in total knee arthroplasty: a meta-analysis of randomized controlled trials
- Zeitschrift:
- BMC Musculoskeletal Disorders > Ausgabe 1/2015
Competing interests
Authors’ contributions
Background
Methods
Inclusion criteria
Literature search
Data collection and quality assessment
Statistical analysis
Results
The characteristics and quality assessment of the included RCTs
Study-year
|
Country
|
Group
|
Patients (male/female)
|
Total TKA
|
Age
|
BMI
|
Follow-up
|
Results favoring
|
---|---|---|---|---|---|---|---|---|
Chiang 2012
|
China
|
QS
|
30 (3/27)
|
38
|
69.7 ± 5.3
|
28.6 ± 3.8
|
2 years
|
MP
|
SP
|
30 (3/27)
|
37
|
69.8 ± 5.4
|
29.6 ± 3.5
|
||||
Karpman 2009
|
America
|
QS
|
20 (8/12)
|
20
|
73 ± 7.4
|
28 ± 4.4
|
6 months
|
QS
|
SP
|
19 (9/10)
|
19
|
73 ± 5.1
|
29 ± 4.6
|
||||
Kim 2007
|
Korea
|
QS
|
120 (27/93)
|
120
|
65.4 (43–88)
|
28.1 (19–36)
|
2 years
|
MP
|
SP
|
120 (27/93)
|
120
|
||||||
Lin 2009
|
China
|
QS
|
30 (3/27)
|
40
|
69.6 (57–78)
|
28.1 (20.1–36.9)
|
2 month
|
N.S
|
SP
|
30 (3/27)
|
40
|
70.2 (56–82)
|
29.0 (20.1–36.9)
|
||||
Lin 2013
|
China
|
QS
|
35 (5/30)
|
35
|
67.7 ± 5
|
26.3 ± 2.5
|
2 years
|
QS
|
SP
|
35 (5/30)
|
35
|
68.5 ± 5.5
|
25.9 ± 2.6
|
||||
Matsumoto 2011
|
Japan
|
QS
|
25 (0/25)
|
25
|
73.8 ± 1.7
|
Not reported
|
1 week
|
QS
|
SP
|
25 (0/25)
|
25
|
73.7 ± 1.4
|
Not reported
|
||||
Shen 2007
|
China
|
QS
|
26 (−/−)
|
26
|
Not reported
|
Not reported
|
12 years
|
QS
|
SP
|
33 (−/−)
|
33
|
Not reported
|
Not reported
|
||||
Tasker 2013
|
United Kingdom
|
QS
|
46 (17/29)
|
46
|
67.3 ± 8.4
|
Not reported
|
2 years
|
QS
|
SP
|
46 (17/29)
|
46
|
68.2 ± 7.5
|
Not reported
|
||||
Xu 2013
|
China
|
QS
|
26 (7/19)
|
35
|
63.5 ± 8.7
|
25.2 ± 3.4
|
3 months
|
QS
|
SP
|
29 (11/18)
|
35
|
64.2 ± 9.3
|
25.2 ± 2.3
|
||||
Roysam 2001
|
United Kingdom
|
SV
|
46 (25/21)
|
46
|
70.2
|
Not reported
|
3 months
|
SV
|
SP
|
43 (22/21)
|
43
|
69.8
|
Not reported
|
||||
Weinhardt 2004
|
German
|
SV
|
26 (19/7)
|
26
|
69.7 ± 9.1
|
Not reported
|
13 days
|
N.S
|
SP
|
26 (14/12)
|
26
|
73.7 ± 6.8
|
Not reported
|
||||
Bridgman 2009
|
United Kingdom
|
SV
|
116 (60/56)
|
116
|
70.1 ± 8.0
|
Not reported
|
1 year
|
SV
|
SP
|
115 (59/56)
|
115
|
70.9 ± 8.1
|
Not reported
|
||||
Sastre 2009
|
Spain
|
SV
|
56 (not reported)
|
56
|
NR
|
Not reported
|
1 year
|
SV
|
SP
|
48 (not reported)
|
48
|
Not reported
|
Not reported
|
||||
Pan 2010
|
China
|
SV
|
35 (11/24)
|
35
|
62.5 (54–70)
|
24.8 (19.5–28.6)
|
18 months
|
N.S
|
SP
|
33 (9/24)
|
33
|
63.2 (50–75)
|
24.6 (19.4–28.2)
|
||||
Varela-Egocheaga
|
Spain
|
SV
|
50 (14/36)
|
50
|
68.02 ± 8.14
|
30.97 ± 5.25
|
3 years
|
SV
|
SP
|
50 (13/37)
|
50
|
70.64 ± 7.88
|
30.62 ± 3.42
|
||||
Van Hemert 2010
|
Netherlands
|
SV
|
20 (6/14)
|
20
|
70.3 ± 11.8
|
29.2 ± 5.5
|
3 months
|
N.S
|
SP
|
20 (7/13)
|
20
|
70.9 ± 7.1
|
30.3 ± 5.9
|
||||
Varnell 2011
|
Italy
|
SV
|
18 (11/7)
|
20
|
71 ± 6
|
30.96 ± 6.16
|
6 months
|
MP
|
SP
|
15 (5/10)
|
18
|
70 ± 7
|
28.15 ± 4.2
|
||||
Wegrzyn 2013
|
USA
|
SV
|
18 (4/14)
|
18
|
71 ± 6
|
30.96 ± 6.16
|
2 months
|
N.S
|
SP
|
18 (4/14)
|
18
|
70 ± 7
|
28.15 ± 4.2
|
||||
Jain 2013
|
India
|
SV
|
50 (12/38)
|
50
|
67 ± 8
|
30 ± 6
|
2 weeks
|
SV
|
SP
|
50 (12/38)
|
50
|
64 ± 7
|
31 ± 4
|
Study
|
Random Sequence Generation
|
Allocation concealment
|
Blinding of participants
|
Blinding of outcome assessment
|
Incomplete Outcome data
|
Selective reporting
|
Other bias
|
---|---|---|---|---|---|---|---|
Kim 2007
|
Yes (Randomization table)
|
Unclear
|
Unclear
|
Yes
|
Yes
|
Unclear
|
Unclear
|
Shen 2007
|
Yes (Not reported)
|
Unclear
|
Unclear
|
Unclear
|
Yes
|
Unclear
|
Unclear
|
Karpman 2009
|
Yes (Computer)
|
Unclear
|
Yes
|
Yes
|
Yes
|
Unclear
|
Unclear
|
Lin 2009
|
Yes (Computer)
|
Yes (Sealed envelope)
|
Yes
|
Yes
|
Yes
|
Unclear
|
Unclear
|
Matsumoto 2011
|
Yes (Not reported)
|
Unclear
|
Yes
|
Unclear
|
Yes
|
Unclear
|
Unclear
|
Chiang 2012
|
Yes (computer)
|
Unclear
|
Yes
|
Yes
|
Yes
|
Yes
|
Unclear
|
Lin 2013
|
Yes (Randomization table)
|
Yes (Sealed envelope)
|
Unclear
|
Yes
|
Yes
|
Unclear
|
Unclear
|
Tasker 2013
|
Yes (Randomization table)
|
Yes (Sealed envelope)
|
Yes
|
Yes
|
Yes
|
Unclear
|
Unclear
|
Xu 2013
|
Yes (Randomization table)
|
Yes (Sealed envelope)
|
Unclear
|
Unclear
|
Yes
|
Unclear
|
Unclear
|
Roysam 2001
|
Yes (Random number table)
|
Yes (Sealed envelope)
|
Yes
|
Yes
|
Yes
|
Unclear
|
Unclear
|
Weinhardt 2004
|
Yes (Not reported)
|
Unclear
|
Unclear
|
Unclear
|
Yes
|
Unclear
|
Unclear
|
Bridgman 2009
|
Yes (Computer)
|
Yes (Telephone)
|
Yes
|
Yes
|
Yes
|
YES
|
Unclear
|
Sastre 2009
|
Yes (Random number table)
|
Yes (Sealed envelope)
|
Yes
|
Yes
|
No
|
Unclear
|
Unclear
|
Pan 2010
|
Yes (Computer)
|
Yes (Sealed envelope)
|
Yes
|
No
|
Yes
|
Unclear
|
Unclear
|
Varela-Egocheaga 2010
|
Yes (Random number table)
|
Unclear
|
Unclear
|
Unclear
|
Yes
|
Unclear
|
Unclear
|
Van Hemert 2010
|
Yes (Not reported)
|
Unclear
|
Yes
|
Yes
|
Yes
|
Unclear
|
Unclear
|
Bourke 2012
|
Yes (Computer)
|
Yes (Sealed envelope)
|
Yes
|
Yes
|
No
|
Unclear
|
Unclear
|
Wegrzyn 2013
|
Yes (Computer)
|
Unclear
|
Yes
|
Yes
|
Yes
|
Unclear
|
Unclear
|
Jain 2013
|
Yes (Computer)
|
Yes (Block schedule)
|
Yes
|
Unclear
|
Yes
|
Unclear
|
Unclear
|
Results of meta-analysis
Quadriceps-sparing versus the standard parapatellar approach
Outcomes
|
Studies
|
No. of TKAs (QS/SP)
|
MD or OR (95 % CI);
p value
|
Heterogeneity
|
|
---|---|---|---|---|---|
KSS 4–6 weeks
|
3
|
101
|
108
|
−0.91 [−3.08, 1.25];
p = 0.41
|
I
2 = 0 %
|
KSS 3 months
|
2
|
138
|
138
|
2.88 [1.17, 4.60];
p = 0.001
|
I
2 = 0 %
|
KSS 2 year
|
2
|
155
|
155
|
1.75 [0.45, 3.06];
p = 0.008
|
I
2 = 0 %
|
VAS 1 weeks
|
4
|
124
|
129
|
−0.69 [−1.10, −0.29];
p < 0.05
|
I
2 = 32 %
|
VAS 4–6 weeks
|
3
|
104
|
110
|
0.14 [−0.29, 0.58];
p = 0.52
|
I
2 = 0 %
|
Total Complication
|
6
|
279
|
287
|
1.00 [0.21, 4.72];
p = 0.49
|
I
2 = 0 %
|
Wound infection
|
6
|
279
|
287
|
1.05 [0.39, 2.85];
p = 0.85
|
I
2 = 0 %
|
Deep vein thrombosis
|
6
|
279
|
287
|
0.67 [0.16, 2.92];
p = 0.30
|
I
2 = 0 %
|
ROM 1 week
|
2
|
64
|
70
|
5.79 [−6.26, 17.85];
p = 0.35
|
I
2 = 89 %
|
ROM 4–6 weeks
|
3
|
99
|
105
|
3.83 [−2.81, 10.46];
p = 0.26
|
I
2 = 84 %
|
ROM 3 months
|
2
|
146
|
153
|
4.37 [−6.41, 15.14];
p = 0.43
|
I
2 = 96 %
|
ROM 12 months
|
2
|
66
|
76
|
10.08 [−7.56, 27.72];
p = 0.26
|
I
2 = 96 %
|
ROM 24 months
|
4
|
233
|
235
|
−0.18 [−1.91, 1.56];
p = 0.84
|
I
2 = 0 %
|
Operative time
|
7
|
319
|
327
|
18.22 [9.92, 26.51];
p < 0.05
|
I
2 = 93 %
|
Blood loss
|
4
|
220
|
222
|
0.80 [−39.34, 40.93];
p = 0.97
|
I
2 = 0 %
|
Hospital stay
|
4
|
215
|
217
|
−0.68 [−1.48, 0.12];
p = 0.10
|
I
2 = 82 %
|
Primary outcomes
Secondary outcomes
Subvastus versus Medial parapatellar approach
Outcomes
|
Studies
|
TKAs (SV/SP)
|
MD or OR [95 % CI];
p value
|
Heterogeneity
|
|
---|---|---|---|---|---|
KSS 4–6 weeks
|
2
|
128
|
127
|
−1.86 [−8.59, 4.88];
p = 0.59
|
I
2 = 66 %
|
KSS 3 months
|
4
|
196
|
195
|
1.03 [−10.28, 12.35];
p = 0.86
|
I
2 = 0 %
|
KSS 12 months
|
2
|
161
|
157
|
3.25 [−0.60, 7.10];
p = 0.10
|
I
2 = 0 %
|
VAS 1 weeks
|
2
|
132
|
133
|
−0.56 [−1.42, 0.29];
p = 0.19
|
I
2 = 98 %
|
VAS 4–6 weeks
|
3
|
182
|
175
|
−0.13 [−0.44, 0.19];
p = 0.44
|
I
2 = 85 %
|
VAS 3 months
|
3
|
182
|
177
|
−0.03 [−0.32, 0.27];
p = 0.87
|
I
2 = 84 %
|
VAS 6 months
|
2
|
165
|
159
|
−0.14 [−0.28, −0.01];
p = 0.04
|
I
2 = 0 %
|
Total Complication
|
6
|
329
|
315
|
0.81 [0.44, 1.49];
p = 0.49
|
I
2 = 0 %
|
Wound infection
|
6
|
242
|
233
|
1.11 [0.40, 3.08];
p = 0.85
|
I
2 = 0 %
|
Deep vein thrombosis
|
5
|
288
|
276
|
5.04 [0.24, 106.22];
p = 0.30
|
I
2 = 0 %
|
ROM 1 week
|
3
|
163
|
166
|
3.96 [3.20, 4.72];
p < 0.05
|
I
2 = 0 %
|
ROM 4–6 weeks
|
4
|
230
|
225
|
3.79 [−0.44, 8.03];
p = 0.08
|
I
2 = 68 %
|
ROM 3 months
|
4
|
230
|
225
|
3.24 [−0.90, 7.38];
p = 0.12
|
I
2 = 72 %
|
ROM 12 months
|
3
|
214
|
206
|
6.80 [0.94, 12.66];
p = 0.02
|
I
2 = 87 %
|
Straight leg raise
|
2
|
59
|
61
|
−2.77 [−4.07, −1.47];
p < 0.05
|
I
2 = 64 %
|
Operative time
|
2
|
46
|
46
|
0.11 [−10.37, 10.58];
p = 0.98
|
I
2 = 60 %
|
Lateral retinacular release
|
4
|
217
|
211
|
0.34 [0.14, 0.79];
p = 0.01
|
I
2 = 0 %
|
Blood loss
|
3
|
81
|
81
|
−100.76 [−223.42, 21.89];
p = 0.11
|
I
2 = 74 %
|